Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antidepressive agents and suicidal tendencies].

G Gründer1, T Veselinović, M Paulzen

  • 1Klinik für Psychiatrie, Psychotherapie und Psychosomatik, RWTH Aachen University, Pauwelsstr. 30, 52074, Aachen, Deutschland, ggruender@ukaachen.de.

Der Nervenarzt
|June 28, 2014
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic reference range for duloxetine in the treatment of depression revised: A systematic review and meta-analysis.

Neuroscience applied·2025
Same author

[Galactorrhea with euprolactinemia under SSRI treatment].

Der Nervenarzt·2025
Same author

Predicting performance in attention by measuring key metabolites in the PCC with 7T MRS.

Scientific reports·2024
Same author

Venlafaxine's therapeutic reference range in the treatment of depression revised: a systematic review and meta-analysis.

Psychopharmacology·2023
Same author

Concentrations of escitalopram in blood of patients treated in a naturalistic setting: focus on patients with alcohol and benzodiazepine use disorder.

European archives of psychiatry and clinical neuroscience·2022
Same author

Correction to: Assessment of Psychosocial Functioning in a Large Cohort of Patients with Schizophrenia.

The Psychiatric quarterly·2022

Antidepressants, including SSRIs and SSNRIs, are generally safe and effective for all ages. While initial agitation can occur, the benefits of treatment outweigh the risks, especially for young patients.

Area of Science:

  • Psychiatry
  • Pharmacology
  • Neuroscience

Context:

  • Recent resurgence in discussions regarding antidepressant-induced suicidality, aggression, and violence.
  • Long-standing debate since the late 1980s concerning selective serotonin reuptake inhibitors (SSRIs) and related antidepressants.
  • Need for a balanced perspective on antidepressant risks versus benefits.

Purpose:

  • To systematically review and synthesize available data on the link between antidepressants and adverse behavioral outcomes.
  • To establish the current scientific consensus on the safety and efficacy of antidepressant pharmacotherapy.
  • To provide guidance on the use of antidepressants, particularly in pediatric and adolescent populations.

Summary:

  • A systematic literature search confirms a scientific consensus: the benefits of antidepressant pharmacotherapy, including SSRIs and SSNRIs, outweigh the risks.

Related Experiment Videos

  • This consensus holds true for children, adolescents, and young adults.
  • Initial treatment-emergent agitation, though potentially aversive, necessitates careful monitoring for suicidal ideation or impulses, especially in susceptible individuals.

    • Impact:

    • Informs clinical practice regarding the risk-benefit profile of antidepressants.
    • Highlights the importance of specialist assessment for initiating antidepressant pharmacotherapy in young patients.
    • Emphasizes vigilant monitoring during the initial phase of antidepressant treatment to mitigate potential risks.